Tilray, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products. The company operates through five segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, Wellness Business, and Business Under Development. It provides medical and adult-use cannabis products; pharmaceutical and wellness products; beverage alcohol products; and hemp-based food and other wellness products. The company offers its products to retailers, wholesalers, patients, physicians, pharmacies, clinics, hospitals, governments, and researchers. It has operations in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company was formerly known as Aphria Inc. Tilray, Inc. was incorporated in 2018 and is based in New York, New York.
IPO Year: 2018
Exchange: NASDAQ
Website: tilray.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/5/2024 | $2.25 → $2.75 | Neutral | Alliance Global Partners |
| 11/2/2022 | $3.90 | Mkt Perform | Bernstein |
| 7/29/2022 | $3.00 | Hold → Sell | The Benchmark Company |
| 3/4/2022 | $9.00 | Hold → Buy | Canaccord Genuity |
| 1/11/2022 | $7.40 → $6.90 | Neutral | Cantor Fitzgerald |
| 1/7/2022 | $11.80 → $7.40 | Neutral | Cantor Fitzgerald |
| 11/18/2021 | $10.00 | Underweight | Barclays |
| 11/1/2021 | $18.00 → $11.80 | Overweight → Neutral | Cantor Fitzgerald |
| 10/8/2021 | $14.00 → $12.00 | Neutral | CIBC |
| 9/17/2021 | $19.00 → $18.00 | Overweight | Cantor Fitzgerald |
8-K - Tilray Brands, Inc. (0001731348) (Filer)
8-K - Tilray Brands, Inc. (0001731348) (Filer)
DEFA14A - Tilray Brands, Inc. (0001731348) (Filer)
8-K - Tilray Brands, Inc. (0001731348) (Filer)
10-Q - Tilray Brands, Inc. (0001731348) (Filer)
10-Q - Tilray Brands, Inc. (0001731348) (Filer)
8-K - Tilray Brands, Inc. (0001731348) (Filer)
DEFA14A - Tilray Brands, Inc. (0001731348) (Filer)
DEF 14A - Tilray Brands, Inc. (0001731348) (Filer)
PRE 14A - Tilray Brands, Inc. (0001731348) (Filer)
TORONTO, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray") (NASDAQ:TLRY, TSX:TLRY), a leading lifestyle and consumer packaged goods company, is excited to announce the launch of its 2024 Holiday Cannabis Gift Guide. The guide features a handpicked selection of cannabis products that are perfect for the festive season. With offerings from Tilray's most popular Canadian cannabis brands, there's something special for everyone on your holiday list. This year, Tilray Brands Canada invites you to spread the holiday cheer with our exclusive cannabis collection. From Broken Coast's premium flower to Good Supply's new vapes, Chowie Wowie's chocolates, Solei's wellness products, and M
Explore Award-Winning Craft Beers, Premium Spirits, Sparkling Water, Non-Alcoholic Brews, and New Hemp-Derived THC Drinks Discover the Best Craft Brews from Across the U.S. at Tilray's Festive Holiday Brewpub Events NEW YORK, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (NASDAQ:TLRY, TSX:TLRY), a leading global lifestyle and consumer packaged goods company, is pleased to present its 2024 holiday spirits and craft beverage gift guide, full of unique gift ideas for your loved ones. This curated selection features new premium spirits, award-winning brews, sparkling water, non-alcoholic brews, and new hemp-derived delta-9 THC drinks from Tilray Brands' portfolio of craft beverage br
NEW YORK, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Blue Point Brewing Company, Long Island's original craft brewery and a subsidiary of Tilray Brands (NASDAQ:TLRY, TSX:TLRY), proudly announces Blitz Beer, a refreshing new American Lager added to Blue Point's winter seasonal lineup. Available November through February, Blitz Beer offers a crisp, sessionable profile perfect for colder months and festive gatherings. New York has a rich tradition of brewing exceptional American lagers, and Blue Point proudly carries on that legacy with Blitz Beer. This award-winning lager, formerly known as "Shouganai," earned a Silver Medal at the 2023 Great American Beer Festival in the Contemporary American-Sty
NEUMÜNSTER, Germany, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, Inc. ("Tilray Brands") (NASDAQ:TLRY, TSX:TLRY) and a global leader in medical cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, today announced the launch of its first commercial German grown medical cannabis flowers from its Aphria RX GmbH ("Aphria RX") facility. This launch marks the first medical cannabis products to be grown in Germany by Aphria RX under the newly issued medical cannabis cultivation license under MedCanG. On July 15, 2024, Tilray Medical was the first to receive a new cannabis cu
BEND, Ore., Nov. 13, 2024 (GLOBE NEWSWIRE) -- 10 Barrel Brewing Co. ("10 Barrel Brewing" or "10 Barrel"), a pioneering craft brewery and subsidiary of Tilray Brands, Inc. (NASDAQ:TLRY, TSX:TLRY), is excited to announce the 13th Annual Pray for Snow Party, a free, all-ages event celebrating the festivities of the winter season, community, and of course, great beer. The event will take place in the evening from 5-10p.m. on Saturday, November 16, 2024, in Bend, Oregon, and promises an evening of excitement and entertainment for the whole community. Attendees can look forward to incredible live performances, numerous giveaways, and free board waxing provided by Powderhouse. Additionally, the
BRECKENRIDGE, Colo., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Breckenridge Distillery, one of the most-awarded craft distilleries in the U.S., and a subsidiary of Tilray Brands, Inc. (NASDAQ:TLRY, TSX:TLRY), releases its new Breckenridge Candy Cane Vodka for the holiday season. Whether enjoyed neat, on the rocks, or as the star ingredient of a favorite holiday cocktail, Breckenridge Distillery's Candy Cane Vodka brings holiday cheer to those aged 21 and up and is now available in retailers nationwide. Breckenridge Candy Cane Vodka is 80 proof / 40% ABV and is available in 750ml and 50ml. The red striped bottles will add a cheerful pop to your holiday tablescapes or make a sweet treat for cockt
ATLANTA, Nov. 12, 2024 (GLOBE NEWSWIRE) -- SweetWater Brewing Company, ("SweetWater Brewing" or "SweetWater"), the hottest craft brewer in Atlanta and the largest in the Southeast, a subsidiary of Tilray Brands, Inc., (NASDAQ:TLRY, TSX:TLRY), has unveiled the headliners for the 2025 420 Fest, marking the festival's 20th anniversary with an epic celebration of music, culture, and great beers. The highly anticipated three-day event, April 18-20 at Atlanta's Historic Pullman Yards, promises unforgettable performances and immersive experiences. Tickets are available now for this milestone festival. Celebrating 20 years of music and culture, SweetWater 420 Fest stays true to its roots with a f
NEW YORK, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (NASDAQ:TLRY, TSX:TLRY), a lifestyle and consumer packaged goods company, announces the launch of "Men's Health on Tap," a new podcast series hosted by distinguished doctors, Dr. John P. Sfakianos, MD, Associate Professor, Department of Urology at the Icahn School of Medicine, and Dr. Steven A. Kaplan, MD, Professor, Department of Urology at the Icahn School of Medicine. The podcast aims to break down stigmas around men's health and invite listeners to an open conversation about important men's health topics. "Men's Health on Tap" is a conversational podcast that covers a wide range of topics, including mental healt
SYDNEY, Australia, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, Inc. ("Tilray Brands") (NASDAQ:TLRY, TSX:TLRY) and a global leader in medical cannabis empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, is pleased to announce the final results of a new scientific study their team has supported titled, "Oral Cannabis Extract for Secondary Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV)." This randomized, placebo-controlled trial aimed to test the effectiveness of an oral cannabis extract in adults suffering from CINV despite standard anti-nausea treatments. Partic
BRECKENRIDGE, Colo., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Breckenridge Brewery, a subsidiary of Tilray Brands, Inc. (NASDAQ:TLRY, TSX:TLRY), today announced an exciting collaboration with the University of Colorado Athletics to bring fans a special edition of its beloved Juice Drop Hazy IPA in a new 19.2 oz. limited-edition can. This exciting partnership celebrates Colorado's rich traditions in both craft beer and collegiate athletics, offering Buffs fans the perfect way to enjoy game day in style. This exciting partnership celebrates Colorado's rich traditions in both craft beer and collegiate athletics, offering Buffs fans the perfect way to enjoy game day in style. The new limited-e
GAINERS: Global Hemp Group (OTC:GBHPF) shares closed up 117.39% at $0.04 CordovaCann (OTC:LVRLF) shares closed up 19.90% at $0.06 SOL Glb Inv (OTC:SOLCF) shares closed up 19.40% at $0.06 1933 Industries (OTC:TGIFF) shares closed up 11.81% at $0.01 Global Compliance (OTC:FUAPF) shares closed up 10.37% at $0.00 CLS Holdings USA (OTC:CLSH) shares closed up 6.01% at $0.04 22nd Century Group (NASDAQ:XXII) shares closed up 4.77% at $0.72 EnWave (OTC:NWVCF) shares closed up 4.53% at $0.17 Psychemedics (NASDAQ:PMD) shares closed up 3.52% at $2.24 cbdMD (AMEX:YCBD) shares closed up 3.11% at $0.63 LOSERS: Green Growth Brands (OTC:GGBXF) shares closed down 99.00% at $1e-06 Leafbuyer Techs (OTC:LBUY)
Cannabis giant Tilray Brands, Inc. (NASDAQ:TLRY) announced Wednesday it has obtained second approval for a new medical marijuana extract in Portugal. The medical cannabis extract that got this approval is Tilray Oral Solution THC10:CBD10. This milestone follows up on the successful approval of Tilray Medical's whole flower THC 18, and approval for the first cannabis extract in Portugal earlier this year. Tilray has been working on its European presence extensively this year. This week the company confirmed its German cannabis cultivation facility, Aphria RX GmbH, has obtained the first new cannabis cultivation license issued under MedCanG, Germany’s new Cannabis Act. Read Also: 90% Of
The cannabis sector witnessed significant movement today, with varied performances across key stocks and ETFs following President Joe Biden’s Sunday announcement that he will not seek re-election. The news created ripples in the market, reflecting investor sentiment and speculation about future regulatory changes. Biggest Winners Aurora Cannabis (NASDAQ:ACB): Increased by 9.04% to $6.02. Positive sentiment is driven by strategic partnerships. Village Farms International (NASDAQ:VFF): Rose by 7.41% to $1.09. The stock benefited from operational efficiency news. Tilray Brands (NASDAQ:TLRY): Saw a rise of 6.70% to $1.87. Investor optimism on future growth prospects in Germany. SNDL (NASD
GAINERS: Leafbuyer Techs (OTC:LBUY) shares closed up 3900.00% at $0.02 Heritage Cannabis Holding (OTC:HERTF) shares closed up 125.00% at $0.00 AusCann Group Holdings (OTC:ACNNF) shares closed up 50.00% at $0.01 Cann Gr (OTC:CNGGF) shares closed up 37.50% at $0.02 Target Group (OTC:CBDY) shares closed up 30.59% at $0.00 Canopy Gwth (NASDAQ:CGC) shares closed up 17.25% at $8.35 RIV Capital (OTC:CNPOF) shares closed up 13.33% at $0.10 GrowGeneration (NASDAQ:GRWG) shares closed up 13.03% at $2.66 Auxly Cannabis Group (OTC:CBWTF) shares closed up 12.60% at $0.03 SNDL (NASDAQ:SNDL) shares closed up 9.66% at $2.27 Aurora Cannabis (NASDAQ:ACB) shares closed up 8.87% at $6.25 Village Farms Intl (NAS
President Joe Biden's announcement that he will not seek re-election has impacted the cannabis stock market. The sector's reaction varied, reflecting investor sentiment and market speculation about future regulatory changes under a potential new administration. This analysis, derived from Benzinga Pro data, highlights the key movements among popular cannabis stocks 24 hours after the announcement. Biggest Losers Several cannabis stocks faced a downturn following the announcement. Curaleaf Holdings (OTC:CURLF) decreased by 1.3986% to $4.23. Jushi Holdings (OTC:JUSHF) dropped by 5.0847%, reaching $0.56. Green Thumb Industries (OTC:GTBIF) fell by 2.3444% to $11.455. Trulieve Cannabis (OTC:TCN
Tilray Brands, Inc. (NASDAQ:TLRY) (TSX:TLRY) announced on Monday that its Germany cannabis cultivation facility, Aphria RX GmbH, has obtained the first new cannabis cultivation license issued under MedCanG, Germany's new Cannabis Act. Why It Matters The new cannabis cultivation license allows Aphria RX to cultivate and manufacture a broad commercial range of medical cannabis, providing patients with better access to high-quality medical cannabis produced in Germany. Denise Faltischek, the company's chief strategy officer and head of international, explained that the license allows Tilray to expand the range of treatment options available to patients. "We appreciate the trust that th
Tilray Brands Inc (NASDAQ:TLRY) shares are trading higher. The company on Monday announced that its cannabis cultivation facility in Germany received the first new cannabis cultivation license issued under Germany’s new Cannabis Act. What To Know: Tilray said Aphria RX GmbH received the first new cannabis cultivation license issued under MedCanG. The license will allow Tilray’s German facility to cultivate and manufacture a broad commercial range of medical cannabis. “We are thrilled to receive this license as it will provide greater access to some of the highest quality medical cannabis produced in Germany and enable us to expand the range of treatment options available to patients,”
Tilray Brands, Inc. ("Tilray") (NASDAQ:TLRY, TSX:TLRY), a global leader in cannabis research, cultivation, production, and distribution, today announced that its Germany cannabis cultivation facility, Aphria RX GmbH ("Aphria RX"), has received the first new cannabis cultivation license issued under MedCanG, Germany's new Cannabis Act. The new cannabis cultivation license allows Aphria RX to cultivate and manufacture a broad commercial range of medical cannabis, providing patients with better access to high-quality medical cannabis produced in Germany.
Tilray Achieves 13% Year-Over-Year Growth, Generating Record Q1 Net Revenue of $200 Million Q1 Gross Margin Increases Over 500 Basis Points, Representing 20% Year-Over-Year Growth Tilray Beverages Achieves 132% Net Revenue Growth, Tilray Alternative Beverages Launched in October to Fuel Key U.S. Markets with Hemp-Derived Delta-9 THC Products German Medical Cannabis Flower Revenue Increases by 50% Following Legalization Conference Call to be Held at 8:30 a.m. ET Today NEW YORK and LEAMINGTON, Ontario, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray", "our", "we" or the "Company") (NASDAQ:TLRY, TSX:TLRY), a leading global lifestyle and consumer packaged goods company, tod
NEW YORK and LEAMINGTON, Ontario, Sept. 30, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (NASDAQ:TLRY, TSX:TLRY), a leading global lifestyle and consumer packaged goods company, today announced that the Company will release its financial results for the first quarter which ended August 31, 2024 before the financial market opens on October 10, 2024. Live Conference Call and Audio Webcast Tilray will host a live conference call, which will be webcast, to discuss these results at 8:30 am Eastern Time. The webcast can be accessed on the Investors section of Tilray's website at www.Tilray.com. Investor Q&A Tilray Brands stockholders can submit and upvote question
Achieved Net Revenue of $188 Million, ~ 30% Net Revenue Growth Over the Prior Year Quarter Beverage-Alcohol Net Revenue Increases 165% Over the Prior Year Quarter, 5th Largest Craft Beer Brewer in the U.S.1 with 4.5% Craft Beer Market Share Global Cannabis Net Revenue Increases 33% with International Cannabis Growth of 44% Over the Prior Year Quarter, #1 Market Share in Canada and #1 Market Share in Germany U.S. Cannabis Strategy in Place to Strike with Potential Drug Policy Reform Conference Call to be Held at 8:30 a.m. ET Today NEW YORK and LEAMINGTON, Ontario, April 09, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray", "our", "we" or the "Company") (NASDAQ:TLRY, TSX:TLRY), a
Record Q2 Net Revenue of $194 Million, Increases 34% Over the Prior Year Period Global Cannabis Leader with #1 Market Share in Canada and 31% Growth in Canadian Cannabis Net Revenue, Medical Cannabis Leader in Europe with 55% Growth in International Cannabis Net Revenue 5th Largest Craft Beer Brewer in the U.S.1, Positioned to Become Top 12 Beverage-Alcohol Company with 117% Increase in Beverage Alcohol Net Revenue Over the Prior Year Period On Track to Achieve $30-$35 Million in Annual Savings related to Integration of HEXO Acquisition Reiterates Financial Guidance for Fiscal Year 2024 Conference Call to be Held at 8:30 a.m. ET Today NEW YORK and LEAMINGTON, Ontario, Jan. 09, 2024 (
Record Q1 Net Revenue of $177 Million, Representing 15% Growth Year over Year Increased #1 Cannabis Market Share Position in Canada to 13.4% Grew Canadian Cannabis Revenue by 16.5% and International Cannabis Revenue by 37% With Closing of Acquisition of Eight Craft Beer and Beverage Brands, Creating 5th Largest U.S. Craft Beer Brewer with 5% Market Share in Growing Craft Market Conference Call to be Held at 8:30 a.m. ET Today NEW YORK and LEAMINGTON, Ontario, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray", "our", "we" or the "Company") (NASDAQ:TLRY, TSX:TLRY), a leading global cannabis-lifestyle and consumer packaged goods company, today reported financial results for
Acquisition Positions Tilray as Leader in Adult-Use Cannabis Beverages in Canada, with a Combined Pro-Forma Market Share of ~36%1 LEAMINGTON, Ontario, Aug. 18, 2023 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray Brands", "Tilray" or the "Company") ((Nasdaq, TSX:TLRY), a leading global cannabis-lifestyle and consumer packaged goods company, today announced the acquisition of the remaining 57.5% equity ownership of Truss Beverage Co.™ (Truss) from Molson Coors Canada (NYSE:TAP). THC beverages present a significant opportunity to engage legal-aged consumers who haven't explored cannabis as a lifestyle, medical, or functional choice. In Canada, with over 10.6 million2 potential consumers r
Record Q4 Net Revenue of $184 Million, Representing 20% Growth Year over Year, $627 Million of Net Revenue for FY2023; On a Constant Currency Basis, FY2023 Net Revenue Grew 6% to $668 Million $8 Million of Net Cash from Operating Activities Generated for FY2023, Achieved Nearly $200 Million Improvement in Adjusted Free Cash Flow Compared to FY2022 Increased Tilray's #1 Cannabis Market Share Position in Canada to 13% with HEXO Acquisition and Substantially Grew Medical Cannabis Market Position Across Europe Company Issues FY2024 Guidance Conference Call to be Held at 8:30 a.m. ET Today NEW YORK and LEAMINGTON, Ontario, July 26, 2023 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray", "o
Delivered $145.6 Million in Net Revenue and 16th Consecutive Quarter of Positive Adjusted EBITDA Maintained #1 Cannabis Market Share Position in Canada, the Largest Federally Legal Cannabis Market in the World; With HEXO Transaction, Poised to Substantially Increase Canadian Revenue Medical Cannabis Leader in Europe Achieved Key Efficiency Milestones on Accelerated Path to Positive Cash Flow, Company Reiterates Cash Flow Guidance LEAMINGTON, Ontario and NEW YORK, April 10, 2023 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (NASDAQ:TLRY, TSX:TLRY), a leading global cannabis-lifestyle and consumer packaged goods company inspiring and empowering the worldwide commun
Achieved $29.2 Million of Operating Cash Flow and $25.4 Million of Free Cash Flow 15th Consecutive Quarter of Positive Adjusted EBITDA Maintains Leading Market Share Position in Recreational Cannabis in Canada and Medical Cannabis Across Europe Net Revenue of $144.1 Million, On a Constant Currency Basis $157.6 million EPS of -$0.11 and Adjusted EPS of -$0.06 Strategy in Place to Build the World's Leading and Most Diversified Cannabis Lifestyle Consumer Packaged Goods Company Completes Acquisition of Montauk Brewing Company, #1 Craft Beer in Metro New York LEAMINGTON, Ontario and NEW YORK, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (NASDAQ:TLRY
FY2022 Net Revenue Grew 22% to $628 Million Compared to the Prior Year; On a Constant Currency Basis, Net Revenue Increased by 29% Fourth Quarter Net Revenue Grew 8% to $153 Million Compared to the Prior Year Period; On a Constant Currency Basis, Net Revenue Increased by 14% to $163 Million Company Expects to Generate $70-$80 Million of Adjusted EBITDA and be Free-Cash Flow Positive in Its Operating Business Units in FY2023 Foundation in Place for Profitable and Sustainable Growth Fourth Quarter International Cannabis Increased 205% from the Prior Year Q4; Tilray Medical Leads European Medical Cannabis Market with 20% Market Share in GermanyDelivered $85 Million in Cost Savings t
Alliance Global Partners reiterated coverage of Tilray with a rating of Neutral and set a new price target of $2.75 from $2.25 previously
Bernstein initiated coverage of Tilray with a rating of Mkt Perform and set a new price target of $3.90
The Benchmark Company downgraded Tilray from Hold to Sell and set a new price target of $3.00
Canaccord Genuity upgraded Tilray from Hold to Buy and set a new price target of $9.00
Cantor Fitzgerald reiterated coverage of Tilray with a rating of Neutral and set a new price target of $6.90 from $7.40 previously
Cantor Fitzgerald reiterated coverage of Tilray with a rating of Neutral and set a new price target of $7.40 from $11.80 previously
Barclays initiated coverage of Tilray with a rating of Underweight and set a new price target of $10.00
Cantor Fitzgerald downgraded Tilray from Overweight to Neutral and set a new price target of $11.80 from $18.00 previously
CIBC reiterated coverage of Tilray with a rating of Neutral and set a new price target of $12.00 from $14.00 previously
Cantor Fitzgerald reiterated coverage of Tilray with a rating of Overweight and set a new price target of $18.00 from $19.00 previously
SC 13G/A - Tilray Brands, Inc. (0001731348) (Subject)
SC 13G - Tilray Brands, Inc. (0001731348) (Subject)
SC 13D - Tilray Brands, Inc. (0001731348) (Filed by)
SC 13D - Tilray, Inc. (0001731348) (Filed by)
SC 13D/A - Tilray, Inc. (0001731348) (Subject)
SC 13D/A - Tilray, Inc. (0001731348) (Subject)
SC 13D/A - Tilray, Inc. (0001731348) (Subject)
SC 13D/A - Tilray, Inc. (0001731348) (Subject)
SC 13G/A - Tilray, Inc. (0001731348) (Subject)
SC 13G/A - Tilray, Inc. (0001731348) (Subject)
4 - Tilray Brands, Inc. (0001731348) (Issuer)
4 - Tilray Brands, Inc. (0001731348) (Issuer)
4 - Tilray Brands, Inc. (0001731348) (Issuer)
4 - Tilray Brands, Inc. (0001731348) (Issuer)
4 - Tilray Brands, Inc. (0001731348) (Issuer)
4 - Tilray Brands, Inc. (0001731348) (Issuer)
4 - Tilray Brands, Inc. (0001731348) (Issuer)
4 - Tilray Brands, Inc. (0001731348) (Issuer)
4 - Tilray Brands, Inc. (0001731348) (Issuer)
4 - Tilray Brands, Inc. (0001731348) (Issuer)
4 - Tilray Brands, Inc. (0001731348) (Issuer)
4 - Tilray Brands, Inc. (0001731348) (Issuer)
4 - Tilray Brands, Inc. (0001731348) (Issuer)
4 - Tilray Brands, Inc. (0001731348) (Issuer)
4 - Tilray Brands, Inc. (0001731348) (Issuer)
4 - Tilray Brands, Inc. (0001731348) (Issuer)
PATCHOGUE, N.Y., Oct. 22, 2024 (GLOBE NEWSWIRE) -- Blue Point Brewing Company, Long Island's original craft brewery and subsidiary of Tilray Brands, (NASDAQ:TLRY, TSX:TLRY), is proud to announce the continuation of its men's health awareness campaign in support of Movember. The month shines a light on key men's health issues—mental health, prostate cancer, and testicular cancer—encouraging open conversations and proactive engagement. To honor the initiative, Blue Point Brewing announced the special release of its classic double IPA, Big Mo, available at our brewery and retailers in Long Island, New York. This hazy double IPA, featuring prominent mosaic hops and an ABV of 8.0%, proud
FORT COLLINS, Colo., Aug. 05, 2024 (GLOBE NEWSWIRE) -- Breckenridge Brewery, a Colorado-based craft brewer with over 30 years of experience brewing approachable, well-balanced beers, announces the opening of its new brewery location in Fort Collins. With doors opening in early August 2024, the new 10,000-square-foot Breckenridge Brewery offers a full restaurant experience and a new vibrant atmosphere in the heart of Fort Collins for all to enjoy. The new location will be a full-service restaurant, upholding the Breckenridge Brewery legacy while ushering in new opportunities for innovation and community collaboration. With a menu boasting a diverse range of culinary delights designed to co
TORONTO, May 30, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (NASDAQ:TLRY, TSX:TLRY), a leading global lifestyle and consumer packaged goods company, today announced the highly anticipated Good Supply® ‘Twisted' All-In-One ("AIO") Vapes hitting the market, offering a revolutionary way to experience its delicious vape flavours. With the ability to switch between complimentary flavours or combining them for a "twist" – creating a unique third flavour experience of the two flavours enjoyed together, Good Supply has a jam packed vape with a series of unique flavour possibilities all-in-one, ready to go for consumers looking for variety that packs a punch. With the new Twisted All-in-One vape
SEATTLE, April 03, 2024 (GLOBE NEWSWIRE) -- Redhook Brewery, makers of pure Pacific Northwest ale, and a subsidiary of Tilray Brands, Inc. (NASDAQ:TLRY, TSX:TLRY), is introducing the brewery's newest offering: Big Juicy Ballard IPA, a higher ABV, high-octane juice bomb bursting with tropical hops and a lingering sweet finish, hitting shelves this April. Redhook's Big Ballard family pays homage to its original stomping grounds in the Ballard District where Redhook was born in 1981 and builds on the resounding success of our beloved Big Ballard series—featuring the Original, Hazy, and Tropical variations. We proudly introduce the newest member: Big Juicy Ballard. With an impressive ABV of 9
MedMen Enterprises Inc. ("MedMen" or the "Company") (CSE:MMEN) (OTCQX:MMNFF), a premier cannabis retailer with operations across the United States, today announced the appointment of Ana Bowman as Chief Financial Officer, effective February 22, 2022. Bowman succeeds outgoing interim CFO Reece Fulgham, who will be returning to consulting firm SierraConstellation Partners. Bowman brings years of cannabis industry expertise, having served as Vice President of Financial Reporting and FP&A of Tilray Brands (NASDAQ:TLRY, TSX:TLRY), a leading global cannabis lifestyle and consumer packaged goods company. Prior to joining Tilray, Bowman served as Corporate Controller of several publicly-traded U.S
Blair MacNeil, Former Bacardi General Manager, Joins Tilray to Lead the Company's Canadian Growth Strategy Tilray, Inc. ("Tilray" or the "Company") (NASDAQ:TLRY, TSX:TLRY) announces the expansion of its leadership team with the appointment of Blair MacNeil as President, Tilray Canada. In his new role, Blair will drive Tilray's next stage of growth in Canada and oversee sales, marketing, and operations across medical and adult-use cannabis businesses. Blair will report to Jim Meiers, who has been appointed to Chief Operations Officer, Tilray, Inc. Irwin D. Simon, Chairman and Chief Executive Officer, stated, "Blair MacNeil has a proven track record in driving accelerated growth for indust
VANCOUVER, BC, Aug. 31, 2021 /PRNewswire/ - Hollister Biosciences Inc. (CSE:HOLL) (OTC:HSTRF) (FRANKFURT: HOB) (the "Company", "Hollister Cannabis Co." or "Hollister") is pleased to announce the appointment of two new members to its Board of Directors: Mr. Kevin Harrington and Mr. Jakob Ripshtein. Mr. Kevin Harrington is a veteran CEO, bestselling author and platform-building entrepreneur known to millions as one of the original "sharks" on the 4x Emmy-winning ABC series Shark Tank. His many landmark achievements include inventing the infomercial, pioneering the As Seen on TV brand, co-founding the Electronic Retailers Association (ERA), serving as a co-founding board member of the Entrepr
High Tide Inc. ("High Tide" or the "Company") (TSXV:HITI) (NASDAQ:HITI) (FRA: 2LYA), a retail-focused cannabis corporation enhanced by the manufacturing and distribution of consumption accessories, today announced that as per the recently disclosed listing of holdings available on its website, the Company's shares have now been included in Horizons Marijuana Life Sciences Index ETF (TSX:HMMJ). "We are very pleased to have our shares included in the Horizons Marijuana Life Sciences Index ETF," said Raj Grover, President and Chief Executive Officer of High Tide. "This is yet more recognition of High Tide's continued execution which has now resulted in another high profile institution acquiri
CALGARY, AB, July 30, 2021 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (TSXV:HITI) (NASDAQ:HITI) (FRA: 2LYA), a retail-focused cannabis corporation enhanced by the manufacturing and distribution of consumption accessories, today announced that as per the recently disclosed listing of holdings available on its website, the Company's shares have now been included in Horizons Marijuana Life Sciences Index ETF (TSX:HMMJ). "We are very pleased to have our shares included in the Horizons Marijuana Life Sciences Index ETF," said Raj Grover, President and Chief Execu
TORONTO, Canada and RIONEGRO, Colombia, May 31, 2021 /CNW/ - PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV:PCLO), (OTCQX:PCLOF), the Canadian parent of Colombia's premier cultivator and producer of medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S., today announced that experienced financial and cannabis executive Ian D. Atacan has been appointed Chief Financial Officer of the Company, effective June 7, 2021, to replace CFO Scott Laitinen, who is retiring, effective June 1, 2021. "PharmaCielo has established a robust operating platform and is no